MedPath
NMPA Approval

Lurasidone Hydrochloride Tablets

国药准字H20249387

November 15, 2024

Drug Information

盐酸鲁拉西酮片

片剂

40mg(按C₂₈H₃₆N₄O₂S·HCl计)

化学药品

November 15, 2024

Company Information

Applicant Company

江西省抚州市东乡区大富工业园区

Manufacturing Company

江西省抚州市东乡区大富工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸鲁拉西酮片 - NMPA 批准文号 | MedPath